Telix Pharmaceuticals Limited (TLX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear

Telix Pharmaceuticals Lim...

NASDAQ: TLX · Real-Time Price · USD
10.28
0.06 (0.59%)
At close: Oct 03, 2025, 3:59 PM
10.28
0.00%
After-hours: Oct 03, 2025, 06:06 PM EDT

Telix Pharmaceuticals Ratios and Metrics

Financials in AUD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
165.07 1.36K -66.32 -73.05
PEG Ratio
0.20 -13 -3.85 -1.03
PS Ratio
10.52 14.12 43.11 774.31
PB Ratio
14.50 47.66 86.27 2.73K
P/FCF Ratio
915.85 542.15 -88.68 -96.95
P/OCF Ratio
191.50 297.13 -107.9 -99.14
OCF/S Ratio
0.05 0.05 -0.4 -7.81
Debt / Equity Ratio
1.02 0.12 0.13 1.18
Quick Ratio
2.66 1.32 1.96 1.16
Current Ratio
2.78 1.43 2.02 1.25
Asset Turnover
0.52 1.26 0.61 0.07
Interest Coverage
3.83 3.83 -226.43 -429.88
Return on Equity
0.09 0.03 -1.3 -37.31
Return on Assets
0.03 0.01 -0.4 -0.73
Return on Invested Capital
0.06 0.36 -0.55 -0.91
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.65 0.63 0.18 -3.92
Net Profit Margin
0.06 0.01 -0.65 -10.6
Pretax Profit Margin
0.07 0.01 -0.62 -13.04
Operating Profit Margin
0.10 0.10 -0.57 -10.7
FCF Margin
0.01 0.03 -0.49 -7.99
EBITDA Margin
0.12 0.05 -0.58 -9.22